Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The colonic epithelial ion transport machinery is a complex functional system comprising various ion channels, transporters, and pumps that regulate the movement of electrolytes and water across the colonic mucosa (Kunzelmann & Mall, 2002). This machinery includes key proteins such as the Epithelial Sodium Channel (ENaC) for sodium absorption, the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) for chloride secretion, and the Sodium-Hydrogen Exchanger 3 (NHE3) (Kiela & Ghishan, 2016). These components work in concert to maintain systemic fluid homeostasis and determine the consistency of fecal matter (Field, 2003). Dysregulation of this machinery is a hallmark of several gastrointestinal disorders, including secretory diarrhea, where chloride secretion is pathologically elevated, and chronic idiopathic constipation, where fluid absorption is excessive (Barrett & Keely, 2015). Therapeutic intervention often involves targeting specific components of this machinery to restore balance. For example, guanylate cyclase-C agonists like linaclotide indirectly activate CFTR and inhibit NHE3 to promote fluid secretion (Waldman & Camilleri, 2018). Other drugs, such as tenapanor, directly inhibit NHE3 to reduce sodium absorption, while crofelemer inhibits chloride channels to treat diarrhea (Tradtrantip et al., 2010). Understanding the interplay between these transporters is essential for developing targeted therapies for irritable bowel syndrome and inflammatory bowel disease.
Activation of CFTR-mediated chloride secretion, inhibition of NHE3-mediated sodium absorption, inhibition of ENaC-mediated sodium absorption, activation of ClC-2 chloride channels, and inhibition of calcium-activated chloride channels.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Colonic epithelial ion transport machinery.